Renaissance Technologies - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 23 filers reported holding DIAMEDICA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$99
+86.8%
64,508
+91.9%
0.00%
Q4 2022$53
-100.0%
33,619
-64.3%
0.00%
-100.0%
Q2 2021$419,000
-70.1%
94,100
-38.5%
0.00%
-50.0%
Q1 2021$1,401,000
+21.8%
153,100
+35.0%
0.00%
+100.0%
Q4 2020$1,150,000
+182.6%
113,400
+18.1%
0.00%
Q3 2020$407,000
-43.9%
96,000
-8.3%
0.00%
-100.0%
Q2 2020$726,000
+908.3%
104,700
+305.0%
0.00%
Q1 2020$72,00025,8490.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,197,245$2,993,0001.24%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 265,000$663,0000.40%
COOPERMAN LEON G 812,508$2,031,2700.11%
Ikarian Capital, LLC 221,252$553,0000.07%
Shay Capital LLC 10,000$25,0000.00%
Sandy Cove Advisors, LLC 1,200$3,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,603$52,0000.00%
Newbridge Financial Services Group, Inc. 1,269$3,0000.00%
Patriot Financial Group Insurance Agency, LLC 1,300$3,0000.00%
GROUP ONE TRADING, L.P. 20$00.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders